Q1 EPS Estimate for Jazz Pharmaceuticals Reduced by Analyst
Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) – Equities research analysts at Zacks Research cut their Q1 2026 earnings estimates for Jazz Pharmaceuticals in a note issued to investors on Tuesday, April 29th. Zacks Research analyst S. Ganoria now anticipates that the specialty pharmaceutical company will post earnings of $3.11 per share for the quarter, […]
Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) – Equities research analysts at Zacks Research cut their Q1 2026 earnings estimates for Jazz Pharmaceuticals in a note issued to investors on Tuesday, April 29th. Zacks Research analyst S. Ganoria now anticipates that the specialty pharmaceutical company will post earnings of $3.11 per share for the quarter, […]
